Nuveen Asset Management, LLC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 76 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$586,968
+5.6%
60,952
-1.3%
0.00%
Q2 2023$556,047
+114548.9%
61,7830.0%0.00%
Q1 2023$485
-50.6%
61,783
-10.4%
0.00%
Q4 2022$982
-99.9%
68,946
-13.6%
0.00%
Q3 2022$1,158,000
+48.7%
79,778
+0.7%
0.00%
Q2 2022$779,000
-19.0%
79,243
+24.0%
0.00%
Q1 2022$962,000
+20.9%
63,905
+1.3%
0.00%
Q4 2021$796,000
-66.1%
63,100
-48.3%
0.00%
-100.0%
Q3 2021$2,351,000
-19.8%
122,122
-0.2%
0.00%0.0%
Q2 2021$2,932,000
+126.1%
122,359
+47.3%
0.00%
Q1 2021$1,297,000
-18.5%
83,090
-0.9%
0.00%
-100.0%
Q4 2020$1,592,000
+14.1%
83,838
-24.3%
0.00%0.0%
Q3 2020$1,395,000
+4.3%
110,791
+0.2%
0.00%0.0%
Q2 2020$1,338,000
+209.0%
110,535
+95.0%
0.00%
Q1 2020$433,000
-38.4%
56,672
+43.5%
0.00%
Q4 2019$703,000
+88.0%
39,479
+22.6%
0.00%
Q3 2019$374,000
-72.7%
32,200
-48.0%
0.00%
-100.0%
Q2 2019$1,372,00061,9060.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 589,270$8,686,0005.61%
GREAT POINT PARTNERS LLC 874,197$12,886,0003.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 383,233$10,805,0002.44%
Frazier Life Sciences Management, L.P. 1,572,192$23,174,0001.98%
TANG CAPITAL MANAGEMENT LLC 648,269$9,555,0001.91%
Deep Track Capital, LP 1,729,757$25,497,0001.64%
Vivo Capital, LLC 1,533,559$22,605,0001.56%
Monashee Investment Management LLC 264,111$3,893,0001.13%
COMMODORE CAPITAL LP 312,553$4,607,0001.03%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,746,300$25,740,0000.79%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders